{"version":"1.0","type":"link","title":"PD-L1 phenotype classification based on expression in tumor and immune cells as a potential biomarker for optimizing anti-PD-1/CTLA-4 immunotherapies in NSCLC.","author_name":"Miyakoshi J 외","author_url":"https://prs-insight.online/author/Miyakoshi%20J","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/100467","thumbnail_width":1200,"thumbnail_height":630}